Will 2017 Trump 2016 for Cannabis Investors

The cannabis sector provided incredible returns during 2016 and many investors are wondering what to expect in 2017.

Despite favorable state-wide elections results in early November, concerns among investors have increased due to some highly questionable cabinet nominations by President-elect Donald Trump.

Although 2016 was a banner year for the cannabis industry, we expect 2017 to be just as significant. From the development of FDA approved pharmaceutical cannabis-based products to the commencement of recreational cannabis sales in Canada, there is a lot for investor to watch this year.

We want to highlight important investment themes for 2017 and provide recommendations based off these themes.

Biotech Breakouts

The biotech sector will be one of the greatest beneficiaries of the legal cannabis movement and recent trends have made us even more bullish on two companies in particular. These companies are Zynerba Pharmaceuticals (ZYNE) and Insys Therapeutics (INSY) and our bullish thesis is...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.